fbpx
QQQ
+ 2.58
328.93
+ 0.78%
DIA
+ 2.29
343.25
+ 0.66%
SPY
+ 2.93
416.17
+ 0.7%
TLT
-0.69
140.61
-0.49%
GLD
+ 1.55
168.49
+ 0.91%

Khiron Receives Approval To Sell Medical Cannabis Products In Colombia

March 21, 2020 5:45 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Khiron Receives Approval To Sell Medical Cannabis Products In Colombia

Vertically integrated cannabis company Khiron Life Sciences Corp. (OTC:KHRNF) has obtained certification of “Good Elaboration Practices for Magistral Preparations with Cannabis” in Colombia. This certification gives the company clearance to sell low-THC medical cannabis to the Colombian market.

“With this GEP certification we begin a new phase in commercializing our medical cannabis product pipeline and towards meeting our market potential. We have been preparing for this day for three years," says Alvaro Torres, CEO and Director of Khiron.

Khiron is alone in being able to sell medical cannabis in Colombia, Chris Naprawa, the company's president, told Benzinga. 

"Today, I saw photos of our very first patients receiving their medicine from one of our couriers and it was simply heartwarming. I know, these patients know, and all our employees know that we are making a difference."

The company has core operations in Latin America. In Colombia it holds licenses for cultivation, production, domestic distribution and international exports of both THC and CBD. 

Khiron said expects to commence filling prescriptions for low-THC cannabis within days, and is anticipating authorization to sell high-THC products within the following weeks.

Photo by Javier Hasse.

Leer Cannabis Medicinal en Colombia: Khiron Autorizado Para Comenzarar Ventas en ElPlanteo.com


Related Articles

Khiron Continues Cross-Border Cannabis Delivery Expansion With The 'DoorDash Of Latin America'

In an effort to expand across Latin America, Khiron Life Sciences Corp. (OTCQX: KHRNF) recently partnered with e-commerce company Rappi to launch and distribute a line of CBD products to Uruguay and Costa Rica. read more

3 Years Into Medical Cannabis, Colombia Looks To Legalize Adult-Use

It’s been three years since Colombia issued Decree 613, regulating cannabis for medical and scientific use across the country. The program has been generally considered successful, and has helped establish a cannabis industry that is leading the region in terms of regulatory development, production capacity and attraction of foreign capital.  read more

Khiron Launches Solar Panel Plant In Colombian Cannabis Facility

Khiron Life Sciences (OTC: KHRNF) has installed the first solar panel plant in Tolima, Colombia for a cannabis production complex.  The company teamed up with ReFeel, a renewable energy company, on the initiative.  read more

UK's Sapphire Medical Funds First Cannabis Treatment, While Khiron Backs Colombia Clinic

Medical marijuana is gaining more traction in international health care systems. read more